Pages Menu
FacebookTwitterPinterestRss
Categories Menu

Posted by on Apr 24, 2015 in Foundation NewsLine |

04/24/2015 ~ Update from Genzyme on Acid Sphingomyelinase Deficiency (ASMD) Development Efforts Pediatric Trial

Genzyme logo
Dear NNPDF Families and Friends,
The NNPDF Central Offices have been notified that Genzyme, a Sanofi Company, has released a statement with additional details about the pediatric Phase 1 / 2 clinical trial of recombinant human acid sphingomyelinase (rhASM).
Visit the NNPDF Enzyme Replacement Therapy web page to view the the statement: https://www.nnpdf.org/npresearch_11.html#Apr24th2015
(function($) { function setup_collapsible_submenus() { var $menu = $('#category_mobile_menu'), top_level_link = '#category_mobile_menu .page_item_has_children > a'; $menu.find('a').each(function() { $(this).off('click'); if ( $(this).is(top_level_link) ) { $(this).attr('href', '#'); } if ( ! $(this).siblings('.children').length ) { $(this).on('click', function(event) { }); } else { $(this).on('click', function(event) { event.preventDefault(); $(this).parent().toggleClass('visible'); }); } }); } $(window).load(function() { setTimeout(function() { setup_collapsible_submenus(); }, 700); }); })(jQuery);